Citigroup Inc Heron Therapeutics, Inc. Put Options Transaction History
Citigroup Inc
- $163 Billion
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding HRTX
# of Institutions
174Shares Held
114MCall Options Held
1.99MPut Options Held
65.8K-
Rubric Capital Management LP New York, NY26.7MShares$44.1 Million0.68% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.5MShares$14 Million0.02% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$13.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.16MShares$13.5 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$11.5 Million22.07% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $196M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...